Delamanid-containing regimens over 24 weeks for the treatment of multidrug-resistant/rifampicin-resistant tuberculosis: preliminary results from a single center in a multicenter, prospective, observational study

BackgroundSingle center preliminary results from a multicenter, prospective, observational study whose aims were to investigate the efficacy and safety of 24-week delamanid-containing regimens in Chinese multidrug-resistant/rifampicin-resistant tuberculosis (MDR/RR-TB) patients.MethodsThe study incl...

全面介紹

書目詳細資料

Principais autores:	Fuping Yang, Mingdan Yin, Xingmei Jiang, Xing Zhao, Xuemei An, Yan Liu, Yijia Yuan
格式:	Artigo
語言:	Inglês
出版:	Frontiers Media S.A. 2025-09-01
叢編:	Frontiers in Medicine
主題:	multidrug-resistant tuberculosis rifampicin-resistant tuberculosis delamanid optimal background regimen sputum culture conversion
在線閱讀:	https://www.frontiersin.org/articles/10.3389/fmed.2025.1631030/full
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!